Drug History: MAXALT-MLT

DRUGS THAT CAUSES A FALSE POSITIVE ON A DRUG TEST

Browse by Letter: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9

Label and Approval History

Drug Name:	MAXALT-MLT
FDA Application No:	(NDA) 020865
Active Ingredient(s):	RIZATRIPTAN BENZOATE
Company:	MERCK

Label History

View the label approved on June 29, 1998 for MAXALTMLT, (NDA) 020865

To see older, previously-approved labels, go to the "Approval History" section of this page. Older labels are for historical information only and should not be used for clinical purposes.

Approval History

Action Date	Supplement Number	Approval Type	Letters, Reviews, Labels, Patient Package Insert
12/6/2001	010	Manufacturing Change or Addition
4/22/2002	009	Labeling Revision	Letter
3/23/2001	008	Manufacturing Change or Addition
12/11/2000	007	Labeling Revision	Review
12/11/2000	006	Efficacy Supplement with Clinical Data to Support	Review
12/11/2000	005	Labeling Revision	Review
6/21/2000	004	Efficacy Supplement with Clinical Data to Support	Review
3/28/2000	003	Control Supplement
6/21/2000	002	Supplement	Review
11/16/1999	001	Efficacy Supplement with Clinical Data to Support	Letter
6/29/1998	000	Approval	Letter Label Review Other Important Information from FDA

There are no Therapeutic Equivalents